Fatma Çiftci
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fatma Çiftci has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
- Serhat Erol
Department of Chest Diseases, Ankara University Faculty of Medicine, Ankara, Türkiye
8 shared publications - Akın Kaya
Department of Chest Diseases, Ankara University Faculty of Medicine, Ankara, Türkiye
6 shared publications - Aslıhan Gürün Kaya
Department of Chest Diseases, Ankara University Faculty of Medicine, Ankara, Türkiye
6 shared publications - Miraç Öz
Department of Chest Diseases, Faculty of Medicine, Ankara University, 06620 Ankara, Türkiye
6 shared publications - Aydın Çiledağ
Ankara Univ, Fac Med, Dept Chest Dis, Ankara, Turkiye
5 shared publications Serhat Erol
Department of Chest Disease, Ankara University School of Medicine, Ankara, Turkey
4 shared publications
Latest Publications
- 14 September 2024
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 64 (suppl 68) , PA1455
Reliability study of pulmonary function tests in patients with chronic obstructive pulmonary disease
COPD is frequently underdiagnosed due to low rates of spirometry utilization and inaccuracies in test quality. This multicenter, prospective, observational study aimed to evaluate the quality of spirometry tests from six tertiary-care-centers, by two pulmonologists. Inter-rater reliability was determined using Cohen's Kappa Test(K). The study included 120 females and 436 males(65.92±10.25 years). 443(79.10%) tests were interpreted as obstruction, 32(5.7%) restriction, 15(2.68%) mixed pattern, 31(5.53%) normal, 31(5.53%) inconclusive, 7(1.25%) small airway obstruction, and 1(0.18%) as upper airway obstruction(K=0.890). Postbronchodilator testing was conducted in 397(71%) tests. Volume-time graphs were included in 495(88.5%), flow-volume loops in 556(99.64%) and inspiratory limbs were present in 550(98.74%) reports. Reference values showed that ESCS, GLI, and NHANES were used in 343(86.4%), 36(8.93%), and 1(0.25%) tests, respectively. The mean values of maximal expiratory flow rates were: FEV1(%predicted) 57.17±23.09, FVC(%predicted) 72.7±24.97, FEV1/FVC(%) 61.91±14.31, FEF25-75(%predicted) 31.81±24.85, and FET(sec) 5.61±1.88. Cough in the first second of FVC was observed in 114(2.55%)(K=0.650), variable-insufficient effort 13.4%(K=0.563), mouth leak 1.8(K=0.305), mouthpiece obstruction 0.5%(K=0.332), rapid expiration 1.8%(K=0.354), increased concavity 83%(K=0.683), and small airway obstruction 87%(K=0.709) were reported by interpreters. The rates of inconclusive and erroneous tests due to variable effort, insufficient effort, mouth leak, mouthpiece obstruction, and rapid expiration are low. Obstructive pattern with increased concavity and small airway obstruction were predominant.
- 14 September 2024
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 64 (suppl 68) , PA1455
Reliability study of pulmonary function tests in patients with chronic obstructive pulmonary disease
COPD is frequently underdiagnosed due to low rates of spirometry utilization and inaccuracies in test quality. This multicenter, prospective, observational study aimed to evaluate the quality of spirometry tests from six tertiary-care-centers, by two pulmonologists. Inter-rater reliability was determined using Cohen's Kappa Test(K). The study included 120 females and 436 males(65.92±10.25 years). 443(79.10%) tests were interpreted as obstruction, 32(5.7%) restriction, 15(2.68%) mixed pattern, 31(5.53%) normal, 31(5.53%) inconclusive, 7(1.25%) small airway obstruction, and 1(0.18%) as upper airway obstruction(K=0.890). Postbronchodilator testing was conducted in 397(71%) tests. Volume-time graphs were included in 495(88.5%), flow-volume loops in 556(99.64%) and inspiratory limbs were present in 550(98.74%) reports. Reference values showed that ESCS, GLI, and NHANES were used in 343(86.4%), 36(8.93%), and 1(0.25%) tests, respectively. The mean values of maximal expiratory flow rates were: FEV1(%predicted) 57.17±23.09, FVC(%predicted) 72.7±24.97, FEV1/FVC(%) 61.91±14.31, FEF25-75(%predicted) 31.81±24.85, and FET(sec) 5.61±1.88. Cough in the first second of FVC was observed in 114(2.55%)(K=0.650), variable-insufficient effort 13.4%(K=0.563), mouth leak 1.8(K=0.305), mouthpiece obstruction 0.5%(K=0.332), rapid expiration 1.8%(K=0.354), increased concavity 83%(K=0.683), and small airway obstruction 87%(K=0.709) were reported by interpreters. The rates of inconclusive and erroneous tests due to variable effort, insufficient effort, mouth leak, mouthpiece obstruction, and rapid expiration are low. Obstructive pattern with increased concavity and small airway obstruction were predominant.
- Open Access
- 28 November 2023
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 25 (1) , 26-34
Recovery from Respiratory Failure in Patients with Coronavirus Disease 2019
COVID-19,long-term oxygen therapy,post COVID,respiratory failure
- 28 November 2023
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 25 (1) , 26-34
Open AccessRecovery from Respiratory Failure in Patients with Coronavirus Disease 2019
COVID-19,long-term oxygen therapy,post COVID,respiratory failure
- 18 October 2022
- Published by Galenos Yayinevi in Journal of Ankara University Faculty of Medicine
- Vol. 75 (3) , 394-399
Clinical and Polysomnographic Differences in Elderly Obstructive Sleep Apnea Patients
- 18 October 2022
- Published by Galenos Yayinevi in Journal of Ankara University Faculty of Medicine
- Vol. 75 (3) , 394-399
Clinical and Polysomnographic Differences in Elderly Obstructive Sleep Apnea Patients
- 1 January 2022
- Published by Springer Nature
- p. 483-489
Clinical Cases in Non Invasive Ventilation: Home Mechanical Ventilation
- 1 January 2022
- Published by Springer Nature
- p. 483-489
Clinical Cases in Non Invasive Ventilation: Home Mechanical Ventilation
- 1 January 2022
- Published by Springer Nature
- p. 465-470
Elderly Non Invasive Mechanical Ventilation Applications
- 1 January 2022
- Published by Springer Nature
- p. 465-470
Elderly Non Invasive Mechanical Ventilation Applications
- 5 September 2021
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 58 (suppl 65) , PA3298
Pulmonary involvement in antisynthetase syndrome: more than myopathy
Antisynthetase syndrome (ASS) is a rare CTD. Pulmonary involvement is the most important guide in predicting prognosis. While investigating the etiology of ILD in the chest diseases outpatient clinic, the characteristics of three subjects diagnosed with ASS were examined (Figure). NSIP was observed in two cases and organized pneumonia in one. Serum autoantibodies were positive against aminoacyl transfer RNA synthetases. Lymphocytosis was observed in BAL. All of them were evaluated by the multidisciplinary team and immunosuppressive therapy was initiated for the patients. Clinical and radiological improvement was detected in all cases during follow-up. Unfortunately Case 2 died in the 3rd year of his follow-up due to metastatic colon adenocancer. ASS is a clinically heterogeneous form of idiopathic inflammatory myopathy characterized by myositis, arthralgia, Raynaud9s phenomenon, mechanic’s hand, ILD, and serum autoantibodies to aminoacyl transfer RNA synthetases. NSIP and organizing pneumonia are the most common forms of ILD. The prognosis is poor in the presence of ILD. It should be kept in mind that the high risk of malignancy in these cases.
- 5 September 2021
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 58 (suppl 65) , PA3298
Pulmonary involvement in antisynthetase syndrome: more than myopathy
Antisynthetase syndrome (ASS) is a rare CTD. Pulmonary involvement is the most important guide in predicting prognosis. While investigating the etiology of ILD in the chest diseases outpatient clinic, the characteristics of three subjects diagnosed with ASS were examined (Figure). NSIP was observed in two cases and organized pneumonia in one. Serum autoantibodies were positive against aminoacyl transfer RNA synthetases. Lymphocytosis was observed in BAL. All of them were evaluated by the multidisciplinary team and immunosuppressive therapy was initiated for the patients. Clinical and radiological improvement was detected in all cases during follow-up. Unfortunately Case 2 died in the 3rd year of his follow-up due to metastatic colon adenocancer. ASS is a clinically heterogeneous form of idiopathic inflammatory myopathy characterized by myositis, arthralgia, Raynaud9s phenomenon, mechanic’s hand, ILD, and serum autoantibodies to aminoacyl transfer RNA synthetases. NSIP and organizing pneumonia are the most common forms of ILD. The prognosis is poor in the presence of ILD. It should be kept in mind that the high risk of malignancy in these cases.
- 12 April 2021
- Published by Bilimsel Tip Publishing House in Tuberk Toraks
- Vol. 69 (1) , 9-20
Göğüs hastalıkları yoğun bakım ünitesinde mikroorganizmaların dağılımı ve antibiyotik direnç profili: Tek merkezli çalışma
- 12 April 2021
- Published by Bilimsel Tip Publishing House in Tuberk Toraks
- Vol. 69 (1) , 9-20
Göğüs hastalıkları yoğun bakım ünitesinde mikroorganizmaların dağılımı ve antibiyotik direnç profili: Tek merkezli çalışma
- 1 January 2021
- Published by Bilimsel Tip Publishing House in Tuberk Toraks
- Vol. 69 (4) , 510-519
Can diaphragm excursion predict prognosis in patients with severe pneumonia?
Introduction: Although thorax ultrasound has been used to diagnose pneumonia in recent years, the role of ultrasonic diaphragm evaluation in the prognosis of pneumonia is unknown. This study aimed to assess the impact of diaphragmatic excursion (Dex) measured by ultrasound on the prognosis of severe pneumonia in critical care patients. Materials and Methods: We prospectively recruited patients with severe pneumonia who were admitted to the intensive care unit (ICU) between January 2019 and July 2021. Patients' Dex values, vital signs, clinical features, laboratory parameters, APACHE-II scores on the first admission day of ICU, mortality and respiratory support status at follow-up were recorded. Results: There were 39 patients enrolled in the study. Mean Dex of the study patients was 30.66 +/- 12.17 mm. Mean Dex was significantly lower in deceased patients than survivors (18.37 +/- 8.12 vs 34.90 +/- 10.36 p< 0.001). Dex was lower in patients who required invasive mechanical ventilation than those not (24.90 +/- 10.93 vs 34.26 +/- 11.70, p= 0.017). The cut-off value of Dex was found 19.0 mm for significantly predicted (p <= 0.001) survival with the sensitivity of 96.6% and specificity of 70%. Among the study group, diaphragm excursion was negatively correlated with APACHE-II score (r=-0.688, p <= 0.001) and respiratory rate (r=-0.531, p= 0.001). Conclusion: Dex measured on the day of ICU admission can be used to evaluate the prognosis of patients with severe pneumonia.
- 1 January 2021
- Published by Bilimsel Tip Publishing House in Tuberk Toraks
- Vol. 69 (4) , 510-519
Can diaphragm excursion predict prognosis in patients with severe pneumonia?
Introduction: Although thorax ultrasound has been used to diagnose pneumonia in recent years, the role of ultrasonic diaphragm evaluation in the prognosis of pneumonia is unknown. This study aimed to assess the impact of diaphragmatic excursion (Dex) measured by ultrasound on the prognosis of severe pneumonia in critical care patients. Materials and Methods: We prospectively recruited patients with severe pneumonia who were admitted to the intensive care unit (ICU) between January 2019 and July 2021. Patients' Dex values, vital signs, clinical features, laboratory parameters, APACHE-II scores on the first admission day of ICU, mortality and respiratory support status at follow-up were recorded. Results: There were 39 patients enrolled in the study. Mean Dex of the study patients was 30.66 +/- 12.17 mm. Mean Dex was significantly lower in deceased patients than survivors (18.37 +/- 8.12 vs 34.90 +/- 10.36 p< 0.001). Dex was lower in patients who required invasive mechanical ventilation than those not (24.90 +/- 10.93 vs 34.26 +/- 11.70, p= 0.017). The cut-off value of Dex was found 19.0 mm for significantly predicted (p <= 0.001) survival with the sensitivity of 96.6% and specificity of 70%. Among the study group, diaphragm excursion was negatively correlated with APACHE-II score (r=-0.688, p <= 0.001) and respiratory rate (r=-0.531, p= 0.001). Conclusion: Dex measured on the day of ICU admission can be used to evaluate the prognosis of patients with severe pneumonia.
- 29 July 2020
- Published by Bilimsel Tip Publishing House in Tuberk Toraks
- Vol. 68 (2) , 168-174
High flow nasal cannula in COVID-19: a literature review
In recent years, high flow nasal cannula (HFNC) is a respiratory support system that has become prominent in the treatment of respiratory failure. HFNC provides higher concentration and flow of oxygen, resulting in decreasing anatomic dead space by preventing rebreathing and ensure positive end-expiratory. However, in COVID-19, the usage of HFNC is much controversial due to concerns about the benefits and risk of aerosol-dispersion. Considering the debates about the use of HFNC, we reviewed the literature related to the usage of HFNC in COVID-19. The available reports suggest that HFNC provides high concentrations of oxygen to the patients, who can not reach with conventional devices. HFNC can reduce the requiring of intubation in patients with COVID-19, and it can decrease the length of intensive care unit stay, and complications related to mechanical ventilation. Also HFNC can in achieving apneic oxygenation in patients during airway management. Besides that, the use of high-flow oxygen cannulas can produce aerosols. So, HFNC treatment should be carried out in a negative pressure room; when it is not possible, devices should be undertaken in a single room.
- 29 July 2020
- Published by Bilimsel Tip Publishing House in Tuberk Toraks
- Vol. 68 (2) , 168-174
High flow nasal cannula in COVID-19: a literature review
In recent years, high flow nasal cannula (HFNC) is a respiratory support system that has become prominent in the treatment of respiratory failure. HFNC provides higher concentration and flow of oxygen, resulting in decreasing anatomic dead space by preventing rebreathing and ensure positive end-expiratory. However, in COVID-19, the usage of HFNC is much controversial due to concerns about the benefits and risk of aerosol-dispersion. Considering the debates about the use of HFNC, we reviewed the literature related to the usage of HFNC in COVID-19. The available reports suggest that HFNC provides high concentrations of oxygen to the patients, who can not reach with conventional devices. HFNC can reduce the requiring of intubation in patients with COVID-19, and it can decrease the length of intensive care unit stay, and complications related to mechanical ventilation. Also HFNC can in achieving apneic oxygenation in patients during airway management. Besides that, the use of high-flow oxygen cannulas can produce aerosols. So, HFNC treatment should be carried out in a negative pressure room; when it is not possible, devices should be undertaken in a single room.
- 1 January 2020
- Published by Bilimsel Tip Publishing House in Tuberk Toraks
- Vol. 68 (4) , 444-448
Successful treatment of COVID-19 infection in a patient with tracheostomy
Coronavirus disease 2019 (COVID-19) has been demonstrated to be the cause of emerging atypical pneumonia. In patients with tracheostomy, coronavirus hypothetically coexists with well-known bacterial agents. A 61-year-old male patient with tracheostomy was admitted to the hospital with dyspnea, fever and increased tracheal secretions. Laboratory findings revealed lymphopenia and elevated C-reactive protein and procalcitonin levels. Chest computed tomography showed consolidation areas and ground-glass opacities more prominent in subpleural areas. Although; two consecutive RT-PCR analyses of combined nasopharengeal/oropharengeal swabs were found to be negative for SARS-CoV-2 RNA, positivity was reported for endotracheal aspirate (ETA) sample. Significant growth of Pseudomonas aeruginosa and Stenotrophomonas maltophilia was detected in the bacterial culture of ETA sample. In conclusion, clinical samples for SARS-CoV-2 should be obtained through the lower respiratory tract, if possible and if upper airway samples are negative. To the best our knowledge, our paper is the first report of the patient with tracheostomy who was treated successfully for COVID-19.
- 1 January 2020
- Published by Bilimsel Tip Publishing House in Tuberk Toraks
- Vol. 68 (4) , 444-448
Successful treatment of COVID-19 infection in a patient with tracheostomy
Coronavirus disease 2019 (COVID-19) has been demonstrated to be the cause of emerging atypical pneumonia. In patients with tracheostomy, coronavirus hypothetically coexists with well-known bacterial agents. A 61-year-old male patient with tracheostomy was admitted to the hospital with dyspnea, fever and increased tracheal secretions. Laboratory findings revealed lymphopenia and elevated C-reactive protein and procalcitonin levels. Chest computed tomography showed consolidation areas and ground-glass opacities more prominent in subpleural areas. Although; two consecutive RT-PCR analyses of combined nasopharengeal/oropharengeal swabs were found to be negative for SARS-CoV-2 RNA, positivity was reported for endotracheal aspirate (ETA) sample. Significant growth of Pseudomonas aeruginosa and Stenotrophomonas maltophilia was detected in the bacterial culture of ETA sample. In conclusion, clinical samples for SARS-CoV-2 should be obtained through the lower respiratory tract, if possible and if upper airway samples are negative. To the best our knowledge, our paper is the first report of the patient with tracheostomy who was treated successfully for COVID-19.